Showing results (121-130 of 131) with videos related to
Sort By:
Pageof 14
Kidney International|June 17, 2020
Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipientsMario Fernández-Ruiz, Daniel Seron, Ángel Alonso, et al.Internal and Emergency Medicine|April 29, 2021
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problemAntonio Lalueza, Jaime Lora-Tamayo, Guillermo Maestro-de la Calle, et al.Preventive Medicine|November 21, 2017
Interaction between cardiovascular risk factors and body mass index and 10-year incidence of cardiovascular disease, cancer death, and overall mortalityMaria Barroso, Albert Goday, Rafel Ramos, et al.Environment International|January 10, 2020
Validation of self-reported perception of proximity to industrial facilities: MCC-Spain studyAdela Castelló, Beatriz Pérez-Gómez, David Lora-Pablos, et al.Lancet (London, England)|June 28, 2021
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trialAlberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, et al.Nature|June 29, 2017
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkineDavid Olmeda, Daniela Cerezo-Wallis, Erica Riveiro-Falkenbach, et al.Diabetes Care|August 6, 2016
Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks AnalysisJose Miguel Baena-Díez, Judit Peñafiel, Isaac Subirana, et al.Iscience|September 17, 2024
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variantsJavier García-Pérez, Alberto M Borobia, Mayte Pérez-Olmeda, et al.Eclinicalmedicine|July 7, 2022
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS studyJavier García-Pérez, María González-Pérez, María Castillo de la Osa, et al.European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.Pageof 14